Vanderbilt University Medical Center: Post-Transplant Complication
July 29, 2020
July 29, 2020
NASHVILLE, Tennessee, July 29 -- Vanderbilt University Medical Center issued the following news:
Hematopoietic stem cell transplantation (HSCT) is a curative treatment for many children with both malignant and non-malignant conditions. Pericardial effusion -- excess fluid around the heart -- is a recognized complication following HSCT, but its incidence, risk factors and impact on mortality are not well defined.
Carrie Kitko, MD, Justin Godown, MD, and colleagues used t . . .
Hematopoietic stem cell transplantation (HSCT) is a curative treatment for many children with both malignant and non-malignant conditions. Pericardial effusion -- excess fluid around the heart -- is a recognized complication following HSCT, but its incidence, risk factors and impact on mortality are not well defined.
Carrie Kitko, MD, Justin Godown, MD, and colleagues used t . . .